177 related articles for article (PubMed ID: 4641434)
21. [Prospective studies on the prevention of manifestations of protodiabetes using sulfonylurea compounds and biguanides].
Adolph W; Panzram G; Ruttmann B
Z Gesamte Inn Med; 1976 Jan; 31(1):1-6. PubMed ID: 969760
[No Abstract] [Full Text] [Related]
22. [Oral antidiabetics].
Standl E
Schwest Rev; 1975 May; 13(5):20-2. PubMed ID: 1040261
[No Abstract] [Full Text] [Related]
23. [Diabetes therapy using oral antidiabetics].
Hasslacher C; Wahl P
Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
[No Abstract] [Full Text] [Related]
24. [Differential therapy using oral antidiabetics].
Mehnert H
Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
[No Abstract] [Full Text] [Related]
25. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
Lunetta M; Presti C; Mughini MT; Mughini L
Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864
[No Abstract] [Full Text] [Related]
26. [Biguanides in the treatment of obesity].
Giulietti M
Clin Ter; 1978 Jan; 84(1):99-100. PubMed ID: 415837
[No Abstract] [Full Text] [Related]
27. [Use of dibotine in treating diabetes mellitus].
Liashko KIa; Oganesova VT
Sov Med; 1971; 34(8):97-100. PubMed ID: 5119658
[No Abstract] [Full Text] [Related]
28. How long are oral antidiabetic drugs effective?
Breidahl HD
Aust Fam Physician; 1976 May; 5(4):445-51. PubMed ID: 952629
[No Abstract] [Full Text] [Related]
29. [Diabetes mellitus and obesity: monotherapy using biguanides].
Bäbler M
Schweiz Med Wochenschr; 1973 Apr; 103(17):641-5. PubMed ID: 4704806
[No Abstract] [Full Text] [Related]
30. [Therapy of senile diabetes].
Bertolini AM; Emanueli A; Sacchetti G; Santagostino A
Minerva Med; 1975 May; 66(34):1605-7. PubMed ID: 1128807
[TBL] [Abstract][Full Text] [Related]
31. [The therapeutic value of combined treatment with biguanides and sulfonylurea preparations in the presence of resistance to sulfanilamide drugs in diabetes mellitus patients].
Penchev I; Andreev D; Popov A; Pampulov L
Probl Endokrinol (Mosk); 1970; 16(6):3-7. PubMed ID: 5521087
[No Abstract] [Full Text] [Related]
32. Drug sales data and prevalence of diabetes in France.
Fontbonne A; Papoz L; Eschwege E
Rev Epidemiol Sante Publique; 1986; 34(2):100-5. PubMed ID: 3738066
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
Jaillard J; Warembourg H
Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
[No Abstract] [Full Text] [Related]
34. [Progress in oral antidiabetic therapy].
Rambert P
Therapeutique; 1973 Nov; 49(9):555-6. PubMed ID: 4600034
[No Abstract] [Full Text] [Related]
35. [Oral antidiabetics today].
Aro A
Duodecim; 1981; 97(12):837-47. PubMed ID: 7297451
[No Abstract] [Full Text] [Related]
36. [Insulin receptors and interference by medication: in vivo and in vitro studies].
Canivet B; Dolais-Kitabgi J; Freychet P
Journ Annu Diabetol Hotel Dieu; 1982; ():61-70. PubMed ID: 7047843
[No Abstract] [Full Text] [Related]
37. [Our experiences with Tolbutaphenone in the treatment of diabetes mellitus].
Grujić M; Perinović M; Rizvanbegović B
Med Arh; 1977; 31(2):97-100. PubMed ID: 904375
[No Abstract] [Full Text] [Related]
38. [On the indication and practical use of oral antidiabetics].
Fankhauser S
Schweiz Med Wochenschr; 1972 Jun; 102(24):856-62. PubMed ID: 5033624
[No Abstract] [Full Text] [Related]
39. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
D'Onofrio F; Pempinello R; Romis L
Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
[No Abstract] [Full Text] [Related]
40. Long term observations with oral hypoglycemic drugs: sulphonylureas, biguanides and their combination.
Patel JC; Dhirawani MK; Doshi JC
Indian J Med Sci; 1970 Jul; 24(7):393-403. PubMed ID: 5523184
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
